Table 2 Correlations between serum and peritoneal fluid concentrations of sHLA-G, IL-10 and TNF-alpha in women with benign serous ovarian cysts, ovarian endometrioma and ovarian cancer (Pearson’s coefficients of linear correlation or Spearman’s coefficients of ran correlation)
Variable | Peritoneal sHLA-G | Serum IL-10 | Peritoneal IL-10 | Serum TNF-alpha | Peritoneal TNF-alpha |
|---|---|---|---|---|---|
Serous cysts (n = 54) | |||||
Serum sHLA-G | 0.07 (p = 0.635) | −0.19 (p = 0.178) | −0.07 (p = 0.637) | 0.13 (p = 0.371) | −0.23 (p = 0.116) |
Peritoneal sHLA-G | 0.13 (p = 0.362) | 0.16 (p = 0.253) | −0.10 (p = 0.483) | 0.06 (p = 0.662) | |
Serum IL-10 | 0.42 (p = 0.002) | 0.35 (p = 0.013) | 0.14 (p = 0.322) | ||
Peritoneal IL-10 | 0.09 (p = 0.527) | 0.42 (p = 0.002) | |||
Serum TNF-alpha | 0.22 (p = 0.133) | ||||
Endometrioma (n = 43) | |||||
Serum sHLA-G | 0.15 (p = 0.348) | −0.06 (p = 0.715) | −0.06 (p = 0.724) | −0.04 (p = 0.800) | −0.06 (p = 0.714) |
Peritoneal sHLA-G | 0.05 (p = 0.754) | 0.10 (p = 0.517) | 0.26 (p = 0.110) | −0.02 (p = 0.875) | |
Serum IL-10 | 0.15 (p = 0.350) | 0.11 (p = 0.495) | −0.16 (p = 0.318) | ||
Peritoneal IL-10 | 0.09 (p = 0.581) | 0.50 (p = 0.001) | |||
Serum TNF-alpha | 0.25 (p = 0.123) | ||||
Ovarian cancer (n = 38) | |||||
Serum sHLA-G | 0.15 (p = 0.389) | 0.04 (p = 0.806) | −0.19 (p = 0.270) | 0.22 (p = 0.201) | −0.03 (p = 0.860) |
Peritoneal sHLA-G | −0.17 (p = 0.328) | −0.11 (p = 0.500) | −0.12 (p = 0.511) | 0.21 (p = 0.205) | |
Serum IL-10 | 0.50 (p = 0.003) | 0.50 (p = 0.003) | −0.12 (p = 0.501) | ||
Peritoneal IL-10 | 0.40 (p = 0.021) | 0.27 (p = 0.106) | |||
Serum TNF-alpha | 0.27 (p = 0.126) | ||||